# MELCHRONO: A Prospective Randomized Study Investigating Chrono-immunotherapy for Advanced Melanoma.

> **NCT07574047** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Swiss Cancer Institute** · enrollment: 108 (estimated)

## Conditions studied

- Melanoma
- Advanced Melanoma

## Interventions

- **DRUG:** Immune Checkpoint Inhibitors
- **DRUG:** Immune Checkpoint Inhibitors

## Key facts

- **NCT ID:** NCT07574047
- **Lead sponsor:** Swiss Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09
- **Primary completion:** 2030-06
- **Final completion:** 2032-06
- **Target enrollment:** 108 (ESTIMATED)
- **Last updated:** 2026-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07574047

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07574047, "MELCHRONO: A Prospective Randomized Study Investigating Chrono-immunotherapy for Advanced Melanoma.". Retrieved via AI Analytics 2026-07-30 from https://api.ai-analytics.org/clinical/NCT07574047. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*